COX-2-specific inhibitors: Prescribing patterns in a large managed care health system and strategies to minimize costs

Medicine & Life Sciences

• rofecoxib 100%
• Cyclooxygenase 2 Inhibitors 82%
• Celecoxib 80%
• Managed Care Programs 80%
• Costs and Cost Analysis 43%
• Health 34%
• Veterans 33%
• Cost Savings 21%
• Prescriptions 16%
• Cyclooxygenase 2 6%
• Linear Models 4%
• Data Analysis 4%
• Regression Analysis 4%
• Confidence Intervals 3%
• Pharmaceutical Preparations 2%

Social Sciences

• managed care 79%
• costs 39%
• savings 35%
• health 31%
• medication 22%
• utilization 14%
• projection 8%
• data analysis 6%
• confidence 6%
• drug 5%
• regression 5%
• trend 4%